跳至主要内容
临床试验/NL-OMON52923
NL-OMON52923招募中不适用

The oropharyngeal microbiome and metabolome as potential novel biomarker for disease progression or treatment response in head and neck squamous cell carcinoma (HNSCC); a pilot study. - Oropharyngeal micro- and metabolome in head and neck cancer.

eids Universitair Medisch Centrum0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • For patients:
  • 1. Age >=18 years
  • 2. T1-4N0-3M0 squamous cell carcinoma of the head and neck.
  • 3. With an indication for curative (C)RT or definitive surgery.
  • 4. WHO 0-2
  • 5. Written informed consent, For healthy volunteers:
  • 1. Age >=18 years

排除标准

  • Incurable HNSCC;
  • Current antibiotic use (topical antibiotics e.g. ear drops, cream are
  • acceptable) ;
  • The presence of any medical condition that might, in the investigators*
  • opinion, render study participation undesirable or that might obscure
  • interpretation of results.

研究者

相似试验